Literature DB >> 17219986

Vascular endothelial growth factor165-regulated nasopharyngeal carcinoma cell lines invasion and migration involve expression and activation of matrix metalloproteinase-2.

Yanjun Wang1, Weijia Kong, Jianxin Yue, Dawei Sun, Wei Li, Qi Yao, Yu Sun, Jihua Dong.   

Abstract

The effect of vascular endothelial growth factor (VEGF) overexpression on matrix metalloproteinase-2 (MMP-2) in nasopharyngeal carcinoma (NPC) cells in vitro and the possible mechanism involved were investigated, and the correlation between the expression of VEGF and MMP-2 in NPC evaluated. The NPC cells were transfected with PAd-trackVEGF165 plasmid. The expression levels of VEGF and MMP-2 mRNA and protein in NPC cells were detected by semi-quantitative RT-PCR and Western blot respectively. It was found that the expression of VEGF and MMP-2 mRNA and protein was significantly increased in NPC cells after transfection of VEGF165. It was concluded that the expression of VEGF was correlated to the in vitro invasion of NPC cells, and the induction of MMP-2 by VEGF was a key process of NPC cell invasion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17219986     DOI: 10.1007/s11596-006-0538-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

Review 1.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

2.  C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors.

Authors:  P O-charoenrat; P H Rhys-Evans; D J Archer; S A Eccles
Journal:  Oral Oncol       Date:  2002-01       Impact factor: 5.337

Review 3.  Matrix metalloproteinases and metastasis.

Authors:  D E Kleiner; W G Stetler-Stevenson
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

4.  Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.

Authors:  S Kurahara; M Shinohara; T Ikebe; S Nakamura; M Beppu; A Hiraki; H Takeuchi; K Shirasuna
Journal:  Head Neck       Date:  1999-10       Impact factor: 3.147

5.  Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.

Authors:  T Kurizaki; M Toi; T Tominaga
Journal:  Oncol Rep       Date:  1998 May-Jun       Impact factor: 3.906

6.  Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.

Authors:  Ryo Kawata; Taketoshi Shimada; Susumu Maruyama; Yasuo Hisa; Hiroshi Takenaka; Yasushi Murakami
Journal:  Acta Otolaryngol       Date:  2002-01       Impact factor: 1.494

7.  Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.

Authors:  G M Abu-Jawdeh; J D Faix; J Niloff; K Tognazzi; E Manseau; H F Dvorak; L F Brown
Journal:  Lab Invest       Date:  1996-06       Impact factor: 5.662

Review 8.  Nasopharyngeal carcinoma.

Authors:  Bernadette Brennan
Journal:  Orphanet J Rare Dis       Date:  2006-06-26       Impact factor: 4.123

9.  Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China.

Authors:  Wei-Hua Jia; Qi-Hong Huang; Jian Liao; Weimin Ye; Y Y Shugart; Qing Liu; Li-Zhen Chen; Yan-Hua Li; Xiao Lin; Fa-Lin Wen; Hans-Olov Adami; Yi Zeng; Yi-Xin Zeng
Journal:  BMC Cancer       Date:  2006-07-06       Impact factor: 4.430

Review 10.  State-of-the-art management of nasopharyngeal carcinoma: current and future directions.

Authors:  M Agulnik; L L Siu
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

View more
  1 in total

1.  Matrix metalloproteinase 2 contributes to aggressive phenotype, epithelial-mesenchymal transition and poor outcome in nasopharyngeal carcinoma.

Authors:  Siyi Li; Weiren Luo
Journal:  Onco Targets Ther       Date:  2019-07-17       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.